Event Detail (Archived)

Nucleoside-modified mRNA-LNP Therapeutics

  • This event already took place in January 2026
  • Caspary Auditorium

Event Details

Type
Harvey Society
Speaker(s)
Drew Weissman, Ph.D., Roberts Family Professor in Vaccine Research, University of Pennsylvania; director, Penn Institute for RNA Innovation
Open to
Public
Reception
Refreshments, 7:30 p.m. - 8:00 p.m., Abby Reception Hall
Phone
(212) 327-8689
Sponsor
Brandon Fleischer
(212) 327-8689
bfleischer@rockefeller.edu

Related News

A protein thought to play a supporting role in DNA replication actually facilitates the whole process

Scientists have discovered that a protein once thought to simply help load a factor necessary for the copying of DNA, actually plays a key role in ensuring fast and reliable replication—an insight that could inform research into cancer and other diseases.

In rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.

A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to this one kind of Chikungunya vaccine, which is no longer available in the U.S.

Study on brain navigation reveals function of an unconventional electrical-signaling mode in neurons

New work in fruit flies uncovers an electrical trick that allows neurons to compute direction efficiently by juggling multiple signaling mechanisms. These findings could reframe our understanding of how some neurons operate.

Related Events

The Fast Tools: Analyzing and Comparing Genomes for Biodiversity Genome Projects

| CARSON FAMILY AUDITORIUM (CRC)
Computational Biology Keynote

Identifying Structure and Modeling Dynamics with Connectome Data

| CARSON FAMILY AUDITORIUM (CRC)

Intro to R

| 305 WRB